Optimum therapeutic program in seropositive nodular rheumatoid arthritis.
D000223:Adaptation, Psychological; D000700:Analgesics / Q000627:therapeutic use; D000740:Anemia / Q000188:drug therapy; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000628:therapy*; D005081:Exercise Therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D009985:Orthopedics; D010653:Phenylbutazone / Q000627:therapeutic use; D012146:Rest; D000074402:Synovectomy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D005938:Glucocorticoids; D009588:Nitrogen Mustard Compounds; D006046:Gold; D010653:Phenylbutazone; D007213:Indomethacin